Search results
Author(s):
Anastasia Shchendrygina
,
Amina Rakisheva
,
Ilya Giverts
,
et al
Added:
8 months ago
Author(s):
Mikhail Kosiborod
Added:
7 months ago
HFSA 24 - We are joined virtually by Dr Mikhail Kosiborod (Saint Luke’s Mid America Heart Institute, US) to discuss findings from the STEP-HFpEF trial programme in regard to the efficacy of semaglutide according to frailty status, and exercise function at baseline.Interview Questions:1. Could you remind us of the importance of STEP-HFpEF2. What was the study design and patient population?3. What…
View more
Author(s):
Helen Colhoun
Added:
7 months ago
EASD 24 - We are joined by Dr Helen Coulhoun (University of Edinburgh, UK) to discuss the key findings of a prespecified analysis of the SELECT trial, which investigated the effectiveness of semaglutide in reducing major cardiac events in the presence of impaired kidney function in patients with overweight and obesity.Findings showed that participants in the study with reduced eGFR and/or…
View more
Author(s):
Angela Cozma
,
Violeta Briciu
,
Adela Viviana Sitar-Tăut
,
et al
Added:
4 weeks ago
Author(s):
Ritu Thamman
,
Naeimeh Hosseini
,
Marie-Luise Dikou
,
et al
Added:
8 months ago
Author(s):
C Noah Nilsson
,
Mads Kristian Ersbøll
,
Finn Gustafsson
Added:
8 months ago
Author(s):
Aleksandra Bykova
,
Maria Serova
,
Maria Chashkina
,
et al
Added:
7 months ago
Red Flags in Acute Myocarditis
Author(s):
Shahrukh Hashmani
,
Yosef Manla
,
Nadya Al Matrooshi
,
et al
Added:
1 year ago
Article
Author(s):
Vincenzo Castiglione
,
Francesco Gentile
,
Nicolò Ghionzoli
,
et al
Added:
1 year ago